Quality of antiretroviral and opportunistic infection medications dispensed from developing countries and Internet pharmacies
- 10 November 2014
- journal article
- Published by Hindawi Limited in Journal of Clinical Pharmacy and Therapeutics
- Vol. 40 (1) , 68-75
Abstract
Generic manufacturers help decrease the cost of antiretroviral (ARV) and antimicrobial medications which are used to treat opportunistic infections (OIs) in developing countries. Concerns have been expressed about potential quality issues with such medications as a result of the identification of numerous counterfeit medications in developing countries. However, few studies have assessed the quality of these medications using the United States Pharmacopeia (USP) compendial standards. The goal of this study was to assess the quality of ARV and OI medications obtained from various sources, including South Africa, United States, China, Ethiopia, Thailand, Laos, Mexico, Nigeria and five Internet pharmacies. Zidovudine, lamivudine, efavirenz, nevirapine, isoniazid and sulfamethoxazole/trimethoprim tablets/capsules were obtained from eight countries and five Internet pharmacies. The tablets/capsules were separated into distinct samples, based on the drug's active ingredient, manufacturer and drug control number. Each distinct sample was analysed for drug content, dissolution, content uniformity and breaking force using USP 32-National Formulary 27 (USP 32-NF 27) compendial methods and compared to the USP standards. A total of 2027 tablets/capsules were obtained with 88 distinct samples identified. All samples met the USP 32-NF 27 standards for drug content with a range of 92.7-108.6%. Six of the 88 samples failed the dissolution test by 1.5-8.3% below the standard range. Ninety-eight per cent of all 88 samples met the USP criteria for content uniformity based on weight variation. One sample of isoniazid was found to have a low breaking force of 2.8 kiloponds. The results of this study show that there were no problems with the samples of ARV and OI medications tested for drug quality from the specified locations. As there are many studies and reports that discuss the poor quality of generic medications with only a few assessing drug quality, the implications of this study's results are to: (i) help better understand patient outcomes; (ii) help patients gain access to beneficial medications for HIV and OIs; and (iii) ensure an overall increase in access to medications where needed. This study is one of the largest to date concerning medication type and sample size for the assessment of ARV and OI medications using drug content as a measure of quality. The samples were obtained from more diverse geographical locations compared to previous studies and, for the first time, included Internet pharmacies. In addition to drug content, this study evaluated a more complete quality profile including dissolution, content uniformity and breaking force. This study showed that drug quality should be assessed consistently in order to better identify counterfeit medications compared to current assessments and that there should be uniform guidelines for how to assess quality.Keywords
Funding Information
- University of Maryland School of Pharmacy's Intramural Seed Grant Program
This publication has 11 references indexed in Scilit:
- Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: 2009 Update by the HIV Medicine Association of the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- South Africa withdraws TB drugs because of quality concernsBMJ, 2008
- Closing the Affordability Gap for Drugs in Low-Income CountriesNew England Journal of Medicine, 2007
- Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine and lamivudineAIDS, 2007
- Dissolution test for lamivudine tablets: Optimization and statistical analysisJournal of Pharmaceutical and Biomedical Analysis, 2006
- Generic HIV Drugs — Enlightened Policy for Global HealthNew England Journal of Medicine, 2005
- Analysis of generic antiretroviral formulations manufactured in IndiaAIDS, 2004
- Antiretroviral Drug Content in Products from Developing CountriesClinical Infectious Diseases, 2004
- In vitro evaluation of the quality of essential drugs on the Tanzanian marketTropical Medicine & International Health, 2002
- Failure of Prescription Prenatal Vitamin Products to Meet USP Standards for Folic Acid DissolutionJournal of the American Pharmaceutical Association, 1997